Jones Financial Companies
ENVB icon

Jones Financial Companies’s Enveric Biosciences ENVB Stock Holding History

Jones Financial Companies’s Portfolio ENVB Stock Details ENVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.42K Hold
1,000
– – ﹤0.01% 4522
2026
Q1 		$1.88K Buy
+1,000
New +$2.73K ﹤0.01% 4165
2025
Q3 		– Hold
0
– -$1 – 4272
2025
Q2 		– Hold
0
– – – 4027

Other funds holding ENVB

SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jones Financial Companies's ENVB Position: Q2 2026 in Review

Jones Financial Companies held its Enveric Biosciences (ENVB) position steady in Q2 2026 at 1,000 shares worth $1.42K. The position accounts for ﹤0.01% of the portfolio, ranked #4522.

Jones Financial Companies first reported a position in ENVB in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.88K in Q1 2026. 24 funds tracked by Wall St. Rank hold ENVB as of Q2 2026.

  • Jones Financial Companies held 1,000 shares of Enveric Biosciences worth $1.42K as of Q2 2026.
  • Jones Financial Companies left its Enveric Biosciences share count unchanged in Q2 2026.
  • Enveric Biosciences made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4522 holding.
  • Jones Financial Companies first reported a position in Enveric Biosciences in Q1 2026 and has held it in 2 quarters since.
  • Jones Financial Companies's Enveric Biosciences position peaked at $1.88K in Q1 2026.
  • 24 funds tracked by Wall St. Rank held Enveric Biosciences as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.